News
Merida raises $121m for Graves drug, and other financings
Our round-up of recent biotech financings includes rounds for Merida, Glycomine, Attovia, Imbria, and Solu Therapeutics.
R&D
Bridging the lab gap: Expanding access to cutting-edge resea...
The global demand for state-of-the-art research facilities is limited by the current supply, leaving many regions unable to support innovation outside of established hubs like Boston, San D
News
Lilly soars on first data for oral obesity candidate
Shares in Eli Lilly rose sharply in pre-market trading today after it reported phase 3 results for oral diabetes and weight-loss drug orforglipron.
News
Spruce Bio sows the seeds of its new future
Spruce has bounced back from the failure of its lead drug last year, thanks to a licensing deal with BioMarin for a late-stage Sanfilippo drug.
R&D
Intelligent regulatory compliance and improved patient outco...
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sonia A. Veluchamy, CEO and co-founder of Celegence.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
